SEC Filing Summary: Form 13F Information Table
Business Context and Reporting Period
Company: Lloyds Banking Group Plc (Reporting Manager)
Filing Type: Form 13F Information Table
Reporting Period: Quarter ended March 31, 2014
This filing discloses the equity securities held by Lloyds Banking Group Plc as of the end of the first quarter of 2014. The document lists individual holdings, share counts, and market values for a diversified portfolio of U.S. and international equities.
Key Financial Metrics
Portfolio Composition: The filing details holdings in over 300 issuers across various sectors, including Financials, Technology, Healthcare, Energy, and Consumer Staples.
Top Holdings by Value (Selected):
- General Electric Co: $6,660,379
- Bank of America Corp: $7,573,836
- Microsoft Corp: $4,702,266
- Wells Fargo & Co: $3,940,949
- AT&T Inc: $3,876,009
- Verizon Communications Inc: $2,544,852
- JPMorgan Chase & Co: $2,554,999
- Oracle Corp: $2,408,305
- Exxon Mobil Corp: $2,842,754
- Pfizer Inc: $4,756,294
Voting Authority: For all listed securities, the reporting manager indicated "Sole" voting authority (Column 7 = 1, Column 8 = 0).
Derivatives: No put or call options were reported in this filing.
Material Changes
The filing text provided is a static snapshot of holdings as of March 31, 2014. It does not contain comparative data from the prior quarter (December 31, 2013) or year-over-year figures. Therefore, material changes in position size, new acquisitions, or divestitures cannot be determined from this document alone.
Guidance, Outlook, and Risks
Management Commentary: None. Form 13F filings are regulatory disclosures of holdings and do not include management commentary, forward-looking guidance, or strategic outlooks.
Risks and Contingencies: The filing includes a standard SEC disclaimer stating that the Commission has not reviewed the information for accuracy or completeness. No specific risk factors or contingencies related to the portfolio are disclosed in this table.
Investor Verification Checklist
- Portfolio Concentration: Verify the total aggregate value of the portfolio to assess the concentration risk relative to Lloyds Banking Group's total assets.
- Position Changes: Compare this filing with the Q4 2013 13F filing to identify significant buys or sells in major positions like Bank of America, Microsoft, or Pfizer.
- Valuation Accuracy: Confirm that the "Value" column reflects the fair market value at the quarter-end date, as required by SEC regulations.
- Regulatory Compliance: Ensure the filing was submitted within the required 45-day window following the quarter-end.
- Derivative Exposure: Cross-reference with other filings to ensure no significant derivative positions were omitted from this specific table.